Sam Slutsky

Stock Analyst at LifeSci Capital

(2.18)
# 2,864
Out of 4,984 analysts
3
Total ratings
66.67%
Success rate
6.44%
Average return
Main Sectors:
Top Industries:

Stocks Rated by Sam Slutsky

Palvella Therapeutics
Aug 4, 2025
Initiates: Outperform
Price Target: $90
Current: $54.51
Upside: +65.11%
ABIVAX Société Anonyme
Jul 23, 2025
Maintains: Outperform
Price Target: $45$101
Current: $82.28
Upside: +22.75%
InflaRx
Apr 5, 2023
Upgrades: Outperform
Price Target: n/a
Current: $1.14
Upside: -